ATRX and central nervous system cancer: Diffuse hemispheric high-grade glioma, H3G34-altered should be suspected in any high-grade hemispheric neoplasm negative for IDH1 and 2, lacking OLIG2 and ATRX nuclear staining, and/or with intense nuclear p53 expression [82].